Cited by 25

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods

Nowak-Jary, Julia, Machnicka, Beata·2025·International Journal of Molecular Sciences

Abstract

With the rapid evolution of nanotechnology, magnetic iron oxide nanoparticles (MNPs)—primarily Fe3O4 and γ-Fe2O3—have gained prominence in biomedicine. Their extensive specific surface area, tunable surface functionalities, and intrinsic magnetic characteristics render them highly versatile for diverse clinical applications, including tumor visualization through Magnetic Resonance Imaging (MRI), radiolabeling, targeted radiotherapy, hyperthermia, gene transfer, drug delivery, Magnetic Particle Imaging (MPI), magnetic blood filtration and theranostic strategies. Nevertheless, ensuring the biocompatibility and non-toxicity of these nanostructures remains a fundamental prerequisite for their medical implementation. Hence, it is essential to continuously refine our understanding of MNP-related toxicity and pursue comprehensive research on this front. This article consolidates up-to-date insights into the evaluation of MNPs’ toxicological profiles, emphasizing the influence of physicochemical properties such as morphology, surface modifications, and electrostatic characteristics, along with operational factors like dosage and administration routes. Traditional toxicity testing strategies, including in vitro assays as first-line screening tools, together with standard ex vivo and in vivo models, are discussed. Special attention is given to the emerging role of New Approach Methodologies (NAMs), such as organoid formation, 3D bioprinting, in ovo chicken embryo assays, and image cytometry. These techniques offer ethical, human-relevant, and informative alternatives to animal testing, supporting more predictive and translationally relevant toxicity assessment of MNPs. Taken together, the integration of conventional assays with innovative NAMs, alongside careful consideration of physicochemical and operational factors, is essential to translate the laboratory promise of MNPs into safe and clinically effective nanomedicines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms26178586

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The main factors influencing the toxicity of MNPs. Several physicochemical and experimental determinants govern the biological effects of magnetic nanoparticles, including particle size, shape, surface charge, and coating molecules, as well as the route and regimen of administration. These parameters can significantly modulate cellular uptake, biodistribution, and the extent of toxic responses, thereby determining the overall safety profile of MNPs in biomedical applications. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).
Figure 1 The main factors influencing the toxicity of MNPs. Several physicochemical and experimental determinants govern the biological effects of magnetic nanoparticles, including particle size, shape, surface charge, and coating molecules, as well as the route and regimen of administration. These parameters can significantly modulate cellular uptake, biodistribution, and the extent of toxic responses, thereby determining the overall safety profile of MNPs in biomedical applications. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).CC BY · PubMed Central
Figure 2 Methods and representative assays used for the evaluation of MNPs toxicity. Toxicological assessment of magnetic nanoparticles relies on a broad spectrum of complementary strategies, including in vitro assays (e.g., tetrazolium-based viability assays, LDH release, NRU (neutral red uptake assay), ROS measurement, genotoxicity and immunotoxicity tests), ex vivo techniques (histology and histopathology), in vivo models (blood biochemistry and hematological analysis), as well as in ovo approaches (e.g., CAM assay, comet assay, hemolysis, oxidative stress evaluation). Together, these methods provide a comprehensive view of MNP-induced biological responses at cellular, tissue, and organismal levels. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).
Figure 2 Methods and representative assays used for the evaluation of MNPs toxicity. Toxicological assessment of magnetic nanoparticles relies on a broad spectrum of complementary strategies, including in vitro assays (e.g., tetrazolium-based viability assays, LDH release, NRU (neutral red uptake assay), ROS measurement, genotoxicity and immunotoxicity tests), ex vivo techniques (histology and histopathology), in vivo models (blood biochemistry and hematological analysis), as well as in ovo approaches (e.g., CAM assay, comet assay, hemolysis, oxidative stress evaluation). Together, these methods provide a comprehensive view of MNP-induced biological responses at cellular, tissue, and organismal levels. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).CC BY · PubMed Central
Figure 3 Conceptual diagram illustrating the main stages of 3D bioprinting of the organ: (a) computational design, (b) bioink preparation, (c) 3D printing of the organ, (d) functional maturation of the tissue. Created with Ideogram.ai. https://ideogram.ai/t/my-images (accessed on 29 July 2025).
Figure 3 Conceptual diagram illustrating the main stages of 3D bioprinting of the organ: (a) computational design, (b) bioink preparation, (c) 3D printing of the organ, (d) functional maturation of the tissue. Created with Ideogram.ai. https://ideogram.ai/t/my-images (accessed on 29 July 2025).CC BY · PubMed Central
Figure 4 Organoid generation through guided self-organization and tissue-specific differentiation. Created in Biorender.com. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).
Figure 4 Organoid generation through guided self-organization and tissue-specific differentiation. Created in Biorender.com. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025).CC BY · PubMed Central
Figure 5 Graphical illustration of the chicken embryo (a) and the CAM (b). The CAM comprises two different layers and a blood vessel system. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025) and Ideogram.ai. https://ideogram.ai/t/my-images (accessed on 29 July 2025).
Figure 5 Graphical illustration of the chicken embryo (a) and the CAM (b). The CAM comprises two different layers and a blood vessel system. Created in Biorender. Julia Nowak-Jary. (2025) https://BioRender.com/ (accessed on 29 July 2025) and Ideogram.ai. https://ideogram.ai/t/my-images (accessed on 29 July 2025).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 169

  1. Stanicki, 2023, An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery, Expert Opin. Drug Deliv., 19, 321, 10.1080/17425247.2022.2047020 · DOI
  2. Avval, 2020, Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application, Drug Metab. Rev., 52, 157, 10.1080/03602532.2019.1697282 · DOI
  3. Wang, 2023, Advances in smart delivery of magnetic field-targeted drugs in cardiovascular diseases, Drug Deliv., 30, 2256495, 10.1080/10717544.2023.2256495 · DOI
  4. Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies, Chem. Rev., 116, 5338, 10.1021/acs.chemrev.5b00589 · DOI
  5. Bao, 2018, Magnetic iron oxide nanoparticles as T1 c ontrast agents for magnetic resonance imaging, J. Mater. Chem. C, 6, 1280, 10.1039/C7TC05854C · DOI
  6. Palzer, J., Eckstein, L., Slabu, I., Reisen, O., Neumann, U.P., and Roeth, A.A. (2021). Iron oxide nanoparticle-based hyperthermia as a treatment option in various gastrointestinal malignancies. Nanomaterials, 11. · DOI
  7. Rahman, 2023, Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine, Nanotheranostics, 7, 424, 10.7150/ntno.86467 · DOI · Paper page
  8. Mahmoudi, 2018, Magnetic hyperthermia therapy for the treatment of glioblastoma: A review of the therapy’s history, efficacy and application in humans, Int. J. Hyperth., 34, 1316, 10.1080/02656736.2018.1430867 · DOI
  9. Mu, 2018, siRNA delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy, ACS Biomater. Sci. Eng., 4, 3895, 10.1021/acsbiomaterials.8b00858 · DOI
  10. Russell, 2021, Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells, Radiat. Oncol., 16, 104, 10.1186/s13014-021-01829-y · DOI
  11. Sizikov, A.A., Nikitin, P.I., and Nikitin, M.P. (2021). Magnetofection in vivo by nanomagnetic carriers systemically administered into the bloodstream. Pharmaceutics, 13. · DOI
  12. Pellico, 2021, Radiolabelling of nanomaterials for medical imaging and therapy, Chem. Soc. Rev., 50, 3355, 10.1039/D0CS00384K · DOI
  13. Rodrigues, 2019, Antimicrobial magnetic nanoparticle-based therapies for controlling infectious diseases, Int. J. Pharm., 555, 356, 10.1016/j.ijpharm.2018.11.043 · DOI
  14. Velazquez-Albino, A.C., Imhoff, E.D., and Rinaldi-Ramos, C.M. (2025). Advances in engineering nanoparticles for magnetic particle imaging (MPI). Sci. Adv., 11. · DOI
  15. Li, Z., Xue, L., Wang, P., Ren, X., Zhang, Y., Wang, C., and Sun, J. (2023). Biological scaffolds assembled with magnetic nanoparticles for bone tissue engineering: A review. Materials, 16. · DOI
  16. Carvalho, T.S.S., Torres, P.M.C., Belo, J.H., Mano, J., and Olhero, S.M. (2023). Bioactive magnetic materials in bone tissue engineering: A review of recent findings in CaP-based particles and 3D-printed scaffolds. Adv. NanoBiomed Res., 3. · DOI
  17. Bauso, L.V., La Fauci, V., Longo, C., and Calabrese, G. (2024). Bone tissue engineering and nanotechnology: A promising combination for bone regeneration. Biology, 13. · DOI
  18. Waalders, N., Van Lier, D., Gerretsen, J., Moran, L., Stegmann, K.A., Twigger, W., Blanco-Andujar, C., Frodsham, G., Kox, M., and Pickkers, P. (2024). Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method. Sci. Rep., 14. · DOI
  19. Wallace, 2016, The regulation of iron absorption and homeostasis, Clin. Biochem. Rev., 37, 51
  20. Meng, 2022, Lysosomal iron recycling in mouse macrophages is dependent upon both LcytB and Steap3 reductases, Blood Adv., 6, 1692, 10.1182/bloodadvances.2021005609 · DOI
  21. Yambire, K.F., Rostosky, C., Watanabe, T., Pacheu-Grau, D., Torres-Odio, S., Sanchez-Guerrero, A., Sendorovich, O., Meyron-Holtz, E.G., Milosevic, J., and Frahm, J. (2019). Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo. eLife, 8. · DOI
  22. Arosio, P., Cairo, G., and Bou-Abdallah, F. (2024). A brief history of ferritin, an ancient and versatile protein. Int. J. Mol. Sci., 26. · DOI
  23. 2010, The iron redox and hydrolysis chemistry of the ferritins, Biochim. Biophys. Acta Gen. Subj., 1800, 719, 10.1016/j.bbagen.2010.03.021 · DOI
  24. Obi, C.D., Bhuiyan, T., Dailey, H.A., and Medlock, A.E. (2022). Ferrochelatase: Mapping the intersection of iron and porphyrin metabolism in the mitochondria. Front. Cell Dev. Biol., 10. · DOI
  25. Maio, 2020, Mammalian iron–sulfur cluster biogenesis: Recent insights into the roles of frataxin, acyl carrier protein and ATPase-mediated transfer to recipient proteins, Curr. Opin. Chem. Biol., 55, 34, 10.1016/j.cbpa.2019.11.014 · DOI
  26. Pearson, S.A., and Cowan, J.A. (2021). Evolution of the human mitochondrial ABCB7 2Fe–2S4 cluster exporter and the molecular mechanism of an E433K disease-causing mutation. Arch. Biochem. Biophys., 697. · DOI
  27. Li, 2022, Structures of Atm1 provide insight into [2Fe-2S] cluster export from mitochondria, Nat. Commun., 13, 4339, 10.1038/s41467-022-32006-8 · DOI
  28. White, 2013, HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis, Cell Metab., 17, 261, 10.1016/j.cmet.2013.01.005 · DOI
  29. Helman, 2023, The biology of mammalian multi-copper ferroxidases, BioMetals, 36, 263, 10.1007/s10534-022-00370-z · DOI
  30. Wang, 2023, Ferritinophagy: Research advance and clinical significance in cancers, Cell Death Discov., 9, 463, 10.1038/s41420-023-01753-y · DOI
  31. Colucci, S., Altamura, S., Marques, O., Müdder, K., Agarvas, A.R., Hentze, M.W., and Muckenthaler, M.U. (2022). Iron-dependent BMP6 regulation in liver sinusoidal endothelial cells is instructed by hepatocyte-derived secretory signals. HemaSphere, 6. · DOI
  32. Camaschella, 2020, Iron metabolism and iron disorders revisited in the hepcidin era, Haematologica, 105, 260, 10.3324/haematol.2019.232124 · DOI · Paper page
  33. 2018, Magnetic iron oxide nanoparticles as drug carriers: Clinical relevance, Nanomedicine, 13, 953, 10.2217/nnm-2017-0336 · DOI
  34. Weissleder, 1989, Superparamagnetic iron oxide: Pharmacokinetics and toxicity, Am. J. Roentgenol., 152, 167, 10.2214/ajr.152.1.167 · DOI
  35. Bulte, 2004, Iron oxide MR contrast agents for molecular and cellular imaging, NMR Biomed., 17, 484, 10.1002/nbm.924 · DOI · Paper page
  36. McCullough, 2013, Ferumoxytol in clinical practice: Implications for MRI, J. Magn. Reson. Imaging, 37, 1476, 10.1002/jmri.23879 · DOI
  37. Ulrich, 2011, Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme, J. Neurooncol., 103, 317, 10.1007/s11060-010-0389-0 · DOI
  38. Johannsen, 2007, Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution, Eur. Urol., 52, 1653, 10.1016/j.eururo.2006.11.023 · DOI
  39. Gonzalez, 2022, Current hurdles to the translation of nanomedicines from bench to the clinic, Drug Deliv. Transl. Res., 12, 500, 10.1007/s13346-021-01024-2 · DOI
  40. Mai, 2017, Magnetic nanoparticles: Reactive oxygen species generation and potential therapeutic applications, J. Nanopart Res., 19, 253, 10.1007/s11051-017-3943-2 · DOI
  41. Abakumov, M.A., Semkina, A.S., Skorikov, A.S., Vishnevskiy, D.A., Ivanova, A.V., Mironova, E., Davydova, G.A., Majouga, A.G., and Chekhonin, V.P. (2018). Toxicity of iron oxide nanoparticles: Size and coating effects. J. Biochem. Mol. Toxicol., 32. · DOI
  42. Machnicka, 2023, In vivo biodistribution and clearance of magnetic iron oxide nanoparticles for medical applications, Int. J. Nanomed., 18, 4067, 10.2147/IJN.S415063 · DOI
  43. Frantellizzi, 2020, New frontiers in molecular imaging with superparamagnetic iron oxide nanoparticles (SPIONs): Efficacy, toxicity, and future applications, Nucl. Med. Mol. Imaging, 54, 65, 10.1007/s13139-020-00635-w · DOI
  44. Yang, 2015, Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice, Nanoscale, 7, 625, 10.1039/C4NR05061D · DOI
  45. Li, J., Yuan, Z., Liu, H., Feng, J., and Chen, Z. (2019). Size-dependent tissue-specific biological effects of core–shell structured Fe3O4@SiO2–NH2 nanoparticles. J. Nanobiotechnol., 17. · DOI
  46. Wu, 2022, Ultrasmall iron oxide nanoparticles cause significant toxicity by specifically inducing acute oxidative stress to multiple organs, Part. Fibre Toxicol., 19, 24, 10.1186/s12989-022-00465-y · DOI
  47. Xie, 2016, Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells, Int. J. Nanomed., 11, 3557, 10.2147/IJN.S105575 · DOI
  48. Kaygisiz, 2017, Genotoxic evaluation of different sizes of iron oxide nanoparticles and ionic form by SMART, Allium and comet assay, Toxicol. Ind. Health, 33, 802, 10.1177/0748233717722907 · DOI
  49. Lee, 2014, Rod-shaped iron oxide nanoparticles are more toxic than sphere-shaped nanoparticles to murine macrophage cells, Environ. Toxicol. Chem., 33, 2759, 10.1002/etc.2735 · DOI
  50. Hu, 2016, External magnetic field-induced targeted delivery of highly sensitive iron oxide nanocubes for MRI of myocardial infarction, Small, 12, 4707, 10.1002/smll.201600263 · DOI
  51. Tonson, 2018, Effects of nanoprobe morphology on cellular binding and inflammatory responses: Hyaluronan-conjugated magnetic nanoworms for magnetic resonance imaging of atherosclerotic plaques, ACS Appl. Mater. Interfaces, 10, 11495, 10.1021/acsami.7b19708 · DOI
  52. Mahmoudi, 2009, Cell toxicity of superparamagnetic iron oxide nanoparticles, J. Colloid Interface Sci., 336, 510, 10.1016/j.jcis.2009.04.046 · DOI
  53. Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri-Fink, A., and Rothen-Rutishauser, B. (2018). Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv. Mater., 30. · DOI
  54. Turrina, C., Klassen, A., Milani, D., Rojas-González, D.M., Ledinski, G., Auer, D., Sartori, B., Cvirn, G., Mela, P., and Berensmeier, S. (2023). Superparamagnetic iron oxide nanoparticles for their application in the human body: Influence of the surface. Heliyon, 9. · DOI
  55. Rabel, 2019, Simulation of the long-term fate of superparamagnetic iron oxide-based nanoparticles using simulated biological fluids, Nanomedicine, 14, 1681, 10.2217/nnm-2018-0382 · DOI
  56. Ajdary, 2021, Potential toxicity of nanoparticles on the reproductive system in animal models: A review, J. Reprod. Immunol., 148, 103384, 10.1016/j.jri.2021.103384 · DOI
  57. Zavisova, 2019, Effect of magnetic nanoparticles coating on cell proliferation and uptake, J. Magn. Magn. Mater., 472, 66, 10.1016/j.jmmm.2018.09.116 · DOI
  58. Alemdar, 2019, Comparison of ionic polymers in the targeted drug delivery applications as the coating materials on the Fe3O4 nanoparticles, Mater. Sci. Eng. C, 103, 109838, 10.1016/j.msec.2019.109838 · DOI
  59. Zheng, 2018, Effects of starch-coating of magnetite nanoparticles on cellular uptake, toxicity and gene expression profiles in adult zebrafish, Sci. Total Environ., 622–623, 930, 10.1016/j.scitotenv.2017.12.018 · DOI
  60. Liu, Y., Xia, Q., Liu, Y., Zhang, S., Cheng, F., Zhong, Z., Wang, L., Li, H., and Xiao, K. (2014). Genotoxicity assessment of magnetic iron oxide nanoparticles with different particle sizes and surface coatings. Nanotechnology, 25. · DOI
  61. Lazaratos, M., Karathanou, K., Mainas, E., Chatzigoulas, A., Pippa, N., Demetzos, C., and Cournia, Z. (2020). Coating of magnetic nanoparticles affects their interactions with model cell membranes. Biochim. Biophys. Acta Gen. Subj., 1864. · DOI
  62. Yang, 2013, Difference between toxicities of iron oxide magnetic nanoparticles with various surface-functional groups against human normal fibroblasts and fibrosarcoma cells, Materials, 6, 4689, 10.3390/ma6104689 · DOI
  63. Blank, 2011, Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells, Nanotoxicology, 5, 606, 10.3109/17435390.2010.541293 · DOI · Paper page
  64. Bhattacharjee, 2010, Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells, Part. Fibre Toxicol., 7, 25, 10.1186/1743-8977-7-25 · DOI
  65. Gokduman, 2018, Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes, Nanomedicine, 13, 1267, 10.2217/nnm-2017-0387 · DOI
  66. Gong, M., Yang, H., Zhang, S., Yang, Y., Zhang, D., Qi, Y., and Zou, L. (2015). Superparamagnetic core/shell GoldMag nanoparticles: Size-, concentration- and time-dependent cellular nanotoxicity on human umbilical vein endothelial cells and the suitable conditions for magnetic resonance imaging. J. Nanobiotechnol., 13. · DOI
  67. Nguyen, 2020, Cytotoxicity, cellular uptake and apoptotic responses in human coronary artery endothelial cells exposed to ultrasmall superparamagnetic iron oxide nanoparticles, J. Appl. Toxicol., 40, 918, 10.1002/jat.3953 · DOI
  68. Lomphithak, T., Helvacioglu, S., Armenia, I., Keshavan, S., Ovejero, J.G., Baldi, G., Ravagli, C., Grazú, V., and Fadeel, B. (2023). High-dose exposure to polymer-coated iron oxide nanoparticles elicits autophagy-dependent ferroptosis in susceptible cancer cells. Nanomaterials, 13. · DOI
  69. Sadeghi, 2015, Toxic effects of the Fe2O3 nanoparticles on the liver and lung tissue, Bratisl. Med. J., 116, 373, 10.4149/BLL_2015_071 · DOI
  70. Aydogan, 2020, Nanotoxicity: A challenge for future medicine, Turk. J. Med. Sci., 50, 1180, 10.3906/sag-1912-209 · DOI
  71. Fakhardo, 2019, Toxicity patterns of clinically relevant metal oxide nanoparticles, ACS Appl. Bio Mater., 2, 4427, 10.1021/acsabm.9b00615 · DOI
  72. Amraeai, 2013, Evaluation of iron oxide nanoparticles effects on tissue and enzymes of thyroid in rats, Int. Res. J. Biol. Sci., 2, 67
  73. Nemmar, 2016, Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice, Part. Fibre Toxicol., 13, 22, 10.1186/s12989-016-0132-x · DOI
  74. Zhao, 2012, A frustrating problem: Accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats, Eur. J. Pharm. Biopharm., 81, 506, 10.1016/j.ejpb.2012.04.023 · DOI
  75. Feng, Q., Liu, Y., Huang, J., Chen, K., Huang, J., and Xiao, K. (2018). Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci. Rep., 8. · DOI
  76. Amin, 2014, Cytotoxicity of magnetic nanoparticles on normal and malignant human skin cells, Nano LIFE, 4, 1440002, 10.1142/S1793984414400029 · DOI
  77. Yu, 2012, Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture, Int. J. Mol. Sci., 13, 5554, 10.3390/ijms13055554 · DOI · Paper page
  78. Jurewicz, 2020, Evaluation of magnetite nanoparticle-based toxicity on embryo–larvae stages of zebrafish (Danio rerio), ACS Appl. Nano Mater., 3, 1621, 10.1021/acsanm.9b02330 · DOI
  79. Kamiloglu, 2020, Guidelines for cell viability assays, Food Front., 1, 332, 10.1002/fft2.44 · DOI
  80. Shukla, 2015, In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles, Toxicol. Rep., 2, 27, 10.1016/j.toxrep.2014.11.002 · DOI
  81. Agotegaray, 2016, Influence of chitosan coating on magnetic nanoparticles in endothelial cells and acute tissue biodistribution, J. Biomater. Sci. Polym. Ed., 27, 1069, 10.1080/09205063.2016.1170417 · DOI
  82. Uggeri, 2004, Calcein-AM is a detector of intracellular oxidative activity, Histochem. Cell Biol., 122, 499, 10.1007/s00418-004-0712-y · DOI
  83. Caro, 2019, Comprehensive toxicity assessment of PEGylated magnetic nanoparticles for in vivo applications, Colloids Surf. B Biointerfaces, 177, 253, 10.1016/j.colsurfb.2019.01.051 · DOI
  84. Nosrati, 2019, Glutathione (GSH) peptide conjugated magnetic nanoparticles as blood–brain barrier shuttle for MRI-monitored brain delivery of paclitaxel, ACS Biomater. Sci. Eng., 5, 1677, 10.1021/acsbiomaterials.8b01420 · DOI
  85. Chandekar, 2021, One-spot fabrication and in vivo toxicity evaluation of core–shell magnetic nanoparticles, Mater. Sci. Eng. C, 122, 111898, 10.1016/j.msec.2021.111898 · DOI
  86. Obireddy, 2022, ROS-generating amine-functionalized magnetic nanoparticles coupled with carboxymethyl chitosan for pH-responsive release of doxorubicin, Int. J. Nanomed., 17, 589, 10.2147/IJN.S338897 · DOI
  87. Do, X.H., Nguyen, T.D., Le, T.T.H., To, T.T., Bui, T.V.K., Pham, N.H., Lam, K., Hoang, T.M.N., and Ha, P.T. (2023). High biocompatibility, MRI enhancement, and dual chemo- and thermal-therapy of curcumin-encapsulated alginate/Fe3O4 nanoparticles. Pharmaceutics, 15. · DOI
  88. Jiang, Y., Xu, X., Lu, J., Yin, C., Li, G., Bai, L., Zhang, T., Mo, J., Wang, X., and Shi, Q. (2023). Development of ε-poly(L-lysine) carbon dots-modified magnetic nanoparticles and their applications as novel antibacterial agents. Front. Chem., 11. · DOI
  89. Berridge, 2005, Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction, Biotechnol. Annu. Rev., 11, 127, 10.1016/S1387-2656(05)11004-7 · DOI · Paper page
  90. Kumar, 2018, Analysis of cell viability by the lactate dehydrogenase assay, Cold Spring Harb. Protoc., 2018, 469
  91. Repetto, 2008, Neutral red uptake assay for the estimation of cell viability/cytotoxicity, Nat. Protoc., 3, 1125, 10.1038/nprot.2008.75 · DOI
  92. Rozhina, 2021, Biocompatibility of magnetic nanoparticles coating with polycations using A549 cells, J. Biotechnol., 325, 25, 10.1016/j.jbiotec.2020.12.003 · DOI
  93. Gillissen, 2016, The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity, J. Immunol. Methods, 434, 16, 10.1016/j.jim.2016.04.002 · DOI
  94. Mieloch, A.A., Żurawek, M., Giersig, M., Rozwadowska, N., and Rybka, J.D. (2020). Bioevaluation of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with dihexadecyl phosphate (DHP). Sci. Rep., 10. · DOI
  95. Weydert, 2010, Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue, Nat. Protoc., 5, 51, 10.1038/nprot.2009.197 · DOI
  96. Csonka, 2015, Measurement of NO in biological samples, Br. J. Pharmacol., 172, 1620, 10.1111/bph.12832 · DOI
  97. Cheng, 2018, Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future, J. Biol. Chem., 293, 10363, 10.1074/jbc.RA118.003044 · DOI
  98. Nakkala, 2018, Green synthesized silver nanoparticles: Catalytic dye degradation, in vitro anticancer activity and in vivo toxicity in rats, Mater. Sci. Eng. C, 91, 372, 10.1016/j.msec.2018.05.048 · DOI
  99. Liao, 2009, The comet assay: A sensitive method for detecting DNA damage in individual cells, Methods, 48, 46, 10.1016/j.ymeth.2009.02.016 · DOI
  100. Nasirzadeh, 2021, 8-Hydroxy-2′-deoxyguanosine (8-OHdG) as a biomarker of oxidative DNA damage induced by occupational exposure to nanomaterials: A systematic review, Nanotoxicology, 15, 850, 10.1080/17435390.2021.1936254 · DOI
  101. Siddiqui, M.A., Wahab, R., Saquib, Q., Ahmad, J., Farshori, N.N., Al-Sheddi, E.S., Al-Oqail, M.M., Al-Massarani, S.M., and Al-Khedhairy, A.A. (2023). Iron oxide nanoparticles induced cytotoxicity, oxidative stress, cell cycle arrest, and DNA damage in human umbilical vein endothelial cells. J. Trace Elem Med. Biol., 76. · DOI
  102. Fontaine, M., Bartolami, E., Prono, M., Béal, D., Blosi, M., Costa, A.L., Ravagli, C., Baldi, G., Sprio, S., and Tampieri, A. (2023). Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay. PLoS ONE, 18. · DOI
  103. Sharma, 2016, Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay using bench top flow cytometer for evaluation of sperm DNA fragmentation in fertility laboratories: Protocol, reference values, and quality control, J. Assist. Reprod. Genet., 33, 291, 10.1007/s10815-015-0635-7 · DOI
  104. Patsula, 2019, Toxicity evaluation of monodisperse PEGylated magnetic nanoparticles for nanomedicine, Nanotoxicology, 13, 510, 10.1080/17435390.2018.1555624 · DOI
  105. Mor, G., and Alvero, A.B. (2008). Caspase activity assays. Apoptosis and Cancer, Humana Press. · DOI
  106. Hofer, S., Hofstätter, N., Punz, B., Hasenkopf, I., Johnson, L., and Himly, M. (2022). Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 14. · DOI
  107. 2005, Inhibition of Na+/K+-ATPase and Mg2+-ATPase by metal ions and prevention and recovery of inhibited activities by chelators, J. Enzyme Inhib. Med. Chem., 20, 469, 10.1080/14756360500213280 · DOI
  108. 2019, Assessment of Na+/K+-ATPase, Mg2+-ATPase, Ca2+-ATPase, and total-ATPase activities in gills of freshwater mussels exposed to penconazole, Commagene J. Biol., 3, 125
  109. Anuje, 2021, Synthesis, characterization, and cytotoxicity evaluation of polyethylene glycol-coated iron oxide nanoparticles for radiotherapy application, J. Med. Phys., 46, 154, 10.4103/jmp.JMP_102_20 · DOI
  110. Prodan, 2013, Iron oxide magnetic nanoparticles: Characterization and toxicity evaluation by in vitro and in vivo assays, J. Nanomater., 2013, 587021, 10.1155/2013/587021 · DOI
  111. Jarockyte, G., Daugelaite, E., Stasys, M., Statkute, U., Poderys, V., Tseng, T.C., Hsu, S.-H., Karabanovas, V., and Rotomskis, R. (2016). Accumulation and toxicity of superparamagnetic iron oxide nanoparticles in cells and experimental animals. Int. J. Mol. Sci., 17. · DOI
  112. Malvindi, M.A., De Matteis, V., Galeone, A., Brunetti, V., Anyfantis, G.C., Athanassiou, A., Cingolani, R., and Pompa, P.P. (2014). Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS ONE, 9. · DOI
  113. Torres, 2011, Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells, Nanotechnology, 22, 205101, 10.1088/0957-4484/22/20/205101 · DOI
  114. Costa, 2016, In vitro cytotoxicity of superparamagnetic iron oxide nanoparticles on neuronal and glial cells: Evaluation of nanoparticle interference with viability tests, J. Appl. Toxicol., 36, 361, 10.1002/jat.3213 · DOI
  115. Hoskins, 2012, Dilemmas in the reliable estimation of the in vitro cell viability in magnetic nanoparticle engineering: Which tests and what protocols?, Nanoscale Res. Lett., 7, 77, 10.1186/1556-276X-7-77 · DOI
  116. Han, 2011, Validation of an LDH assay for assessing nanoparticle toxicity, Toxicology, 287, 99, 10.1016/j.tox.2011.06.011 · DOI
  117. Reddy, 2017, Biomarkers of oxidative stress for in vivo assessment of toxicological effects of iron oxide nanoparticles, Saudi J. Biol. Sci., 24, 1172, 10.1016/j.sjbs.2015.09.029 · DOI
  118. Pongrac, 2016, Oxidative stress response in neural stem cells exposed to different superparamagnetic iron oxide nanoparticles, Int. J. Nanomed., 11, 1701
  119. Radu, 2015, Magnetite nanoparticles induced adaptive mechanisms counteract cell death in human pulmonary fibroblasts, Toxicol. Vitr., 29, 1492, 10.1016/j.tiv.2015.06.002 · DOI
  120. Gaharwar, 2017, Iron oxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in lymphocytes, J. Appl. Toxicol., 37, 1232, 10.1002/jat.3485 · DOI
  121. Seo, 2017, Investigation of the genetic toxicity by dextran-coated superparamagnetic iron oxide nanoparticles in HepG2 cells using the comet assay and cytokinesis-block micronucleus assay, Toxicol. Environ. Health Sci., 9, 23, 10.1007/s13530-017-0299-z · DOI
  122. Jacewicz, D., Siedlecka-Kroplewska, K., Drzeżdżon, J., Piotrowska, A., Wyrzykowski, D., Tesmar, A., Żamojć, K., and Chmurzyński, L. (2017). Method for detection of hydrogen peroxide in HT22 cells. Sci. Rep., 7. · DOI
  123. Erofeev, A., Gorelkin, P., Garanina, A., Alova, A., Efremova, M., Vorobyeva, N., Edwards, C., Korchev, Y., and Majouga, A. (2018). Novel method for rapid toxicity screening of magnetic nanoparticles. Sci. Rep., 8. · DOI
  124. Cellai, F., Munnia, A., Viti, J., Doumett, S., Ravagli, C., Ceni, E., Mello, T., Polvani, S., Giese, R.W., and Baldi, G. (2017). Magnetic hyperthermia and oxidative damage to DNA of human hepatocarcinoma cells. Int. J. Mol. Sci., 18. · DOI
  125. Woo, S., Kim, S., Kim, H., Cheon, Y.W., Yoon, S., Oh, J.H., and Park, J. (2021). Charge-modulated synthesis of highly stable iron oxide nanoparticles for in vitro and in vivo toxicity evaluation. Nanomaterials, 11. · DOI
  126. Radosinska, J., Jasenovec, T., Radosinska, D., Balis, P., Puzserova, A., Skratek, M., Manka, J., and Bernatova, I. (2021). Ultra-small superparamagnetic iron-oxide nanoparticles exert different effects on erythrocytes in normotensive and hypertensive rats. Biomedicines, 9. · DOI
  127. Ruíz-Baltazar, Á.D.J., Reyes-López, S.Y., Méndez-Lozano, N., and Juárez-Moreno, K. (2024). Evaluation of superparamagnetic Fe3O4-Ag decorated nanoparticles: Cytotoxicity studies in human fibroblasts (HFF-1) and breast cancer cells (MCF-7). Appl. Sci., 14. · DOI
  128. Paulini, F., Marangon, A.R.M., Azevedo, C.L., Brito, J.L.M., Lemos, M.S., Sousa, M.H., Veiga-Sonza, F.H., Sonza, P.E.N., Lucci, C.M., and Azevedo, R.B. (2022). In vivo evaluation of DMSA-coated magnetic nanoparticle toxicity and biodistribution in rats: A long-term follow-up. Nanomaterials, 12. · DOI
  129. Rogoveanu, 2022, Liver histopathological changes related to intraperitoneal administration of salicylic acid/Fe3O4 nanoparticles to C57BL/6 mice, Curr. Health Sci. J., 48, 146
  130. Sewell, F., Alexander-White, C., Brescia, S., Currie, R.A., Roberts, R., Roper, C., Vickers, C., Westmoreland, C., and Kimber, I. (2024). New approach methodologies (NAMs): Identifying and overcoming hurdles to accelerated adoption. Toxicol. Res., 13. · DOI
  131. Usmani, S.M., Bremer-Hoffmann, S., Cheyns, K., Cubadda, F., Dumit, V.I., Escher, S.E., Fessard, V., Gutleb, A.C., Léger, T., and Liu, Y.-C. (2024). Review of new approach methodologies for application in risk assessment of nanoparticles in the food and feed sector: Status and challenges. EFSA Support. Publ., 21. · DOI
  132. Yang, 2024, Applications of 3D organoids in toxicological studies: A comprehensive analysis based on bibliometrics and advances in toxicological mechanisms, Arch. Toxicol., 98, 2309, 10.1007/s00204-024-03777-4 · DOI
  133. Gerbolés, A.G., Galetti, M., Rossi, S., Lo Muzio, F.P., Pinelli, S., Delmonte, N., Malvezzi, C.C., Macaluso, C., Miragoli, M., and Foresti, R. (2023). Three-dimensional bioprinting of organoid-based scaffolds (OBST) for long-term nanoparticle toxicology investigation. Int. J. Mol. Sci., 24. · DOI
  134. Groll, J., Boland, T., Blunk, T., Burdick, J.A., Cho, D.W., Dalton, P.D., Derby, B., Forgacs, G., Li, Q., and Mironov, V.A. (2016). Biofabrication: Reappraising the definition of an evolving field. Biofabrication, 8. · DOI · Paper page
  135. Li, 2020, Inkjet bioprinting of biomaterials, Chem. Rev., 120, 10793, 10.1021/acs.chemrev.0c00008 · DOI
  136. Mandrycky, 2016, 3D bioprinting for engineering complex tissues, Biotechnol. Adv., 34, 422, 10.1016/j.biotechadv.2015.12.011 · DOI
  137. Li, 2016, Recent advances in bioprinting techniques: Approaches, applications and future prospects, J. Transl. Med., 14, 271, 10.1186/s12967-016-1028-0 · DOI
  138. Daly, 2021, Bioprinting for the biologist, Cell, 184, 18, 10.1016/j.cell.2020.12.002 · DOI
  139. Theus, A.S., Ning, L., Kabboul, G., Hwang, B., Tomov, M.L., LaRock, C.N., Bauser-Heaton, H., Mahmoudi, M., and Serpooshan, V. (2022). 3D bioprinting of nanoparticle-laden hydrogel scaffolds with enhanced antibacterial and imaging properties. iScience, 25. · DOI
  140. Ning, 2024, Targeted rapamycin delivery via magnetic nanoparticles to address stenosis in a 3D bioprinted in vitro model of pulmonary veins, Adv. Sci., 11, 2400476, 10.1002/advs.202400476 · DOI
  141. Palzer, 2021, Magnetic fluid hyperthermia as treatment option for pancreatic cancer cells and pancreatic cancer organoids, Int. J. Nanomed., 16, 2965, 10.2147/IJN.S288379 · DOI
  142. Sun, A., Hayat, H., Liu, S., Tull, E., Bishop, J.O., Dwan, B.F., Gudi, M., Talebloo, N., Dizon, J.R., and Li, W. (2021). 3D in vivo magnetic particle imaging of human stem cell-derived islet organoid transplantation using a machine learning algorithm. Front. Cell Dev. Biol., 9. · DOI
  143. Yazdani, M. (2014). In Vitro, In Ovo and In Vivo Models for Cytotoxicity, Oxidative Stress, Neurotoxicity and DNA Damage. [Ph.D. Thesis, Oslo University Hospital]. Available online: https://www.researchgate.net/publication/342241588.
  144. Ghimire, 2022, Use of chicken embryo model in toxicity studies of endocrine-disrupting chemicals and nanoparticles, Chem. Res. Toxicol., 35, 550, 10.1021/acs.chemrestox.1c00399 · DOI
  145. Sarnella, A., Ferrara, Y., Terlizzi, C., Albanese, S., Monti, S., Licenziato, L., and Mancini, M. (2024). The chicken embryo: An old but promising model for in vivo preclinical research. Biomedicines, 12. · DOI
  146. Ribatti, 2008, Chapter 5: Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis, Int. Rev. Cell Mol. Biol., 266, 181, 10.1016/S1937-6448(08)01405-6 · DOI
  147. Ribatti, 2014, The chick embryo chorioallantoic membrane as a model for tumor biology, Exp. Cell Res., 328, 314, 10.1016/j.yexcr.2014.06.010 · DOI
  148. Auerbach, 2000, Angiogenesis assays: Problems and pitfalls, Cancer Metastasis Rev., 19, 167, 10.1023/A:1026574416001 · DOI
  149. Tufan, 2005, The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents, Curr. Cancer Drug Targets, 5, 249, 10.2174/1568009054064624 · DOI
  150. Patel, 2019, Toxicity evaluation of magnetic iron oxide nanoparticles reveals neuronal loss in chicken embryo, Drug Chem. Toxicol., 42, 1, 10.1080/01480545.2017.1413110 · DOI
  151. Akbari, 2022, Morphological assessment of iron oxide nanoparticles effects on the chicken embryo: Teratogenic aspect, ASJ, 19, 89
  152. Scheschenja, M., Jedelská, J., Juchems, E., Weinmann, M., Pagenstecher, A., Helmprobst, F., Buchholz, M., Tatura, M., Schaefer, J., and Bakowsky, U. (2025). Chick chorioallantoic membrane model as a preclinical platform for cryoablation studies. Eur. Radiol. Exp., 9. · DOI
  153. Tkachenko, 2022, Flow cytometry in nanotoxicology: Brief overview, Inter Collegas, 8, 278, 10.35339/ic.8.4.278-289 · DOI
  154. Monteiro-Riviere, N.A., and Tran, C.L. (2014). Advanced methodologies and techniques for assessing nanomaterial toxicity. Nanotoxicology, CRC Press. · DOI
  155. Gupta, 2019, Deep learning in image cytometry: A review, Cytom. A, 95, 366, 10.1002/cyto.a.23701 · DOI
  156. Rees, 2022, Imaging flow cytometry, Nat. Rev. Methods Primers, 2, 67, 10.1038/s43586-022-00167-x · DOI
  157. Eustaquio, T., and Leary, J.F. (2012). Single-cell nanotoxicity assays of superparamagnetic iron oxide nanoparticles. Methods in Molecular Biology, Humana Press. · DOI
  158. Eustaquio, 2016, Nanobarcoded superparamagnetic iron oxide nanoparticles for nanomedicine: Quantitative studies of cell–nanoparticle interactions by scanning image cytometry, Cytom. A, 89, 207, 10.1002/cyto.a.22699 · DOI
  159. Friedrich, 2015, Flow cytometry for intracellular SPION quantification: Specificity and sensitivity in comparison with spectroscopic methods, Int. J. Nanomed., 10, 4185, 10.2147/IJN.S82714 · DOI
  160. Polasky, C., Studt, T., Steuer, A.K., Loyal, K., Lüdtke-Buzug, K., Bruchhage, K.L., and Pries, R. (2022). Impact of superparamagnetic iron oxide nanoparticles on THP-1 monocytes and monocyte-derived macrophages. Front. Mol. Biosci., 9. · DOI
  161. Jiang, 2021, Ferroptosis: Mechanisms, biology and role in disease, Nat. Rev. Mol. Cell Biol., 22, 266, 10.1038/s41580-020-00324-8 · DOI
  162. Kuno, S., Fujita, H., Tanaka, Y., Ogra, Y., and Iwai, K. (2022). Iron-induced NCOA4 condensation regulates ferritin fate and iron homeostasis. Embo Rep., 23. · DOI
  163. Ucar, 2022, Magnetic nanoparticles-induced neurotoxicity and oxidative stress in brain of rainbow trout: Mitigation by ulexite through modulation of antioxidant, anti-inflammatory, and antiapoptotic activities, Sci. Total Environ., 838, 155718, 10.1016/j.scitotenv.2022.155718 · DOI
  164. Bardestani, A., Ebrahimpour, S., Esmaeili, A., and Esmaeili, A. (2021). Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles. J. Nanobiotechnology, 19. · DOI
  165. Bouwmeester, M.C., Bernal, P.N., Oosterhoff, L.A., Van Wolferen, M.E., Lehmann, V., Vermaas, M., Bucholz, M.-B., Peiffer, Q.C., Malda, J., and van der Laan, L.J.W. (2021). Bioprinting of human liver-derived epithelial organoids for toxicity studies. Macromol. Biosci., 21. · DOI
  166. Krewski, 2010, Toxicity testing in the 21st century: A vision and a strategy, J. Toxicol. Environ. Health B Crit. Rev., 13, 51, 10.1080/10937404.2010.483176 · DOI
  167. Hartung, 2021, The state of the scientific revolution in toxicology, ALTEX, 38, 3, 10.14573/altex.2101051 · DOI
  168. DeLoid, 2017, Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials, Nat. Protoc., 12, 355, 10.1038/nprot.2016.172 · DOI
  169. Nelissen, I., Haase, A., Anguissola, S., Rocks, L., Jacobs, A., Willems, H., Riebeling, C., Luch, A., Piret, J.-P., and Toussaint, O. (2020). Improving quality in nanoparticle-induced cytotoxicity testing by a tiered inter-laboratory comparison study. Nanomaterials, 10. · DOI

Cited by

Sorted by citations

See all 25

Metadata

Authors
Nowak-Jary, J., & Machnicka, B.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2025-09-03
Volume
26
Issue
17
Pages
8586
ISSN
1422-0067
Cited by
25
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods. https://app.cochat.ai/papers/10.3390/ijms26178586
The paper
Nowak-Jary, J., & Machnicka, B. (2025). Toxicity of Magnetic Nanoparticles in Medicine: Contributing Factors and Modern Assessment Methods. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178586